跳至主要内容
临床试验/NL-OMON38400
NL-OMON38400已完成不适用

Effect of vitamin D supplementation on pulmonary function, airway infections and physical performance in patients with COPD: a randomized controlled trial - Vitamin D supplementation and pulmonary function

Vrije Universiteit Medisch Centrum0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Written informed consent
  • - Aged between 40 and 70 years
  • - Postbronchodilator FEV1/FVC <70% and FEV1 <80% (GOLD-stages I-IV) and diagnosis COPD confirmed by the pulmonologist:
  • - Vitamin D deficiency (defined as a serum 25-hydroxyvitamin D < 50 nmol/l)
  • - Ability to comply with all study requirements

排除标准

  • - Severe vitamin D deficiency (serum 25-hydroxyvitamin D <15 nmol/L),
  • - Life expectation of less than 6 months on the basis of concurrent disease
  • - Interfering malignant diseases.
  • - Serious mental impairment i.e. preventing to understand the study protocol or comply with the study aim; potentially unreliable patients and those judged by the investigator to be unsuitable for the study.
  • - Pregnant or lactating women, or subjects who intend to become pregnant within the study period.
  • - Clinical suspicion of osteoporosis

研究者

相似试验